( February 14, 2024, 2:30 PM EST) -- CINCINNATI — The federal judge presiding over the Onglyza multidistrict litigation “had three good reasons to find” that testimony by an expert retained to opine that the drug is capable of causing heart failure was inadmissible, a Sixth Circuit U.S. Court of Appeals panel said Feb. 13, affirming the final judgment entered in the case....